Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol MECP2 contributors: mct/pgu/shn - updated : 01-02-2017
HGNC name methyl CpG binding protein 2 (Rett syndrome)
HGNC id 6990
ASSOCIATED DISORDERS
corresponding disease(s) RTT , RTTM , MRX28 , PPMX , MRXS31 , ESMR , DUPXQ28
related resource RettBASE
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
constitutional germinal mutation      
in sporadic RTT, mutation exclusively of paternal origin
constitutional somatic mutation      
somatic mosaicism in male (with classic RTT syndrome)
constitutional   amplification    
duplication in mental retardation in males
constitutional germinal mutation      
in autism sporadic, rare cases
tumoral     --over  
in cancer prostate cells
constitutional     --other loss of function
a 50p100 decrease in MECP2 levels might indeed cause disease, and misregulation may be a common feature of many neurodevelopmental disorders
constitutional       loss of function
neural cell fate and neuronal maintenance may be perturbed by senescence triggered by impaired MECP2 activity either before or after neural differentiation (
Susceptibility
  • to sporadic autism
  • to reduced cortical surface area
  • Variant & Polymorphism other common MECP2 haplotype associates with reduced cortical surface area
    Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    mental retardationother 
    a lower dosage of gentamicin was enough to increase full-length MECP2 levels in RTT neurons, rescuing glutamatergic synapses
    mental retardationother 
    various steps in the cholesterol pathway may be valid targets for treatment of Rett sdr
    ANIMAL & CELL MODELS
  • overexpression of MeCP2 in the mouse heart causes embryonic lethality with cardiac septum hypertrophy and dysregulated expression of MeCP2 in skeletal tissue produces severe malformations
  • mice bearing a hypomorphic mutation in Mecp2 display altered behavioral responses to acute and repeated AMPH treatment and changes in both the development and plasticity of striatal synapses
  • in globally MeCP2-deficient mice, re-expression of Mecp2 preferentially in astrocytes significantly improved locomotion and anxiety levels, restored respiratory abnormalities to a normal pattern, and greatly prolonged lifespan compared to globally null mice
  • neuron-specific deletion of MeCP2 recapitulates the RTT symptoms of the whole-body KO mouse, implicating an essential role for MeCP2 in neurons
  • decreased dopamine transmission due to heterogeneous Mecp2 expression contributes to the parkinsonian features of RTT in Mecp2(+/-) mice
  • mutations occurring in Rett patients are defective in the chromatin architecture function of MeCP2
  • cholesterol homeostasis is disrupted in Mecp2 mutant mice
  • loss of MECP2 causes mislocalization of the ATRX in the hippocampus and cortex of symptomatic KO mice